K. K. Pharma Solutions

Andheri West, Mumbai, Maharashtra

Gazyva 1000mg Solution for Infusion is used in the treatment of blood cancer (chronic lymphocytic leukemia). It binds to the receptors on cancer cells. Thus, it flags the cancer cells for destruction by the body's immune system.

Gazyva 1000mg Solution for Infusion is given as an injection into the veins under the supervision of a doctor. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. Take it exactly as advised by the doctor. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nasopharyngitis (inflammation of the throat and nasal passages), upper respiratory tract infection, rash, flu, dermatitis, and eczema. Let your doctor know if any of these side effects bother you or persist for longer. Regular blood tests are required to check your blood cell count and the heart, liver, and kidney functions.
Before taking Gazyva 1000mg Solution for Infusion, tell your doctor if you have heart disease, liver or kidney problems, or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine, so let your doctor know about all the medications you are using. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during the treatment is important to avoid pregnancy.

There is a Patient Support Program / Patient Assistance Program available in India for this medicine, being managed by Tata 1mg. Please contact your prescribing doctor to know more about the same. You may also call on (1800-102-1618) for more details.

Bavencio Injection is a medicine used for treatment of urinary bladder cancer that has metastasized (spread to other parts) or has reached the advanced stage in adults and children aged above 12 years. It restores those immune responses in the body that stop cancer growth.

Bavencio Injection is given as an injection by a healthcare professional. For it to be effective, complete the course of the medicine and do not discontinue even if you get better until the course is completed.

Some common side effects of this medicine include fatigue, nausea, diarrhea, decreased appetite, and muscle pain amongst others. These are usually mild and go away with time. However, if they persist or get worse, let the doctor know.

Before receiving the medicine, you should let your doctor if you have ever had an allergic reaction to any medicine. Also tell your doctor if you have any problems with your heart, kidneys, or liver. Some other medicines may react with this medicine, so let your doctor know of all the medication you are taking. Pregnant or breastfeeding should consult their doctors first before receiving this medicine.

Imfinzi 500mg Injection is an anticancer drug used to treat several cancers, including non-small cell lung cancer, biliary tract cancer, liver cancer, and endometrial cancer. It works by blocking the PD-L1 protein on cancer cells. This allows the immune system to recognize and attack these cells more effectively.

Imfinzi 500mg Injection is administered as an intravenous infusion, typically given in a hospital or a clinical setting. Make sure to attend all scheduled appointments and follow your doctors instructions. Maintaining a healthy lifestyle, including a balanced diet and regular exercise, can help optimize the treatment's effectiveness.

Common side effects include fatigue, cough, nausea, and loss of appetite. Some patients may experience diarrhea, skin rash, or shortness of breath. If you experience severe or persistent side effects, contact your doctor immediately. Staying hydrated and reporting side effects early can help manage them effectively.

While on Imfinzi 500mg Injection, avoid activities that can increase your risk of infection, such as contact with sick individuals or large crowds. The drug can cause immune-related side effects, such as inflammation of the lungs, liver, or intestines, so report any unusual symptoms promptly.

Imfinzi 500mg Injection is not recommended for individuals with certain autoimmune conditions or those who are pregnant or breastfeeding, as it may pose risks to the fetus or infant. Before receiving this injection, inform your doctor about any other medications you are taking to avoid interactions. Always discuss your medical history and any concerns with your doctor before starting treatment.

Tevimbra 100mg Injection is an anti-cancer immunotherapy used to treat esophageal and gastric (stomach) cancers. It improves the immune system by blocking the PD-1 pathway, helping immune cells detect and destroy cancer cells more effectively.

Adhering to the Tevimbra 100mg Injection treatment is essential for its effectiveness. It is given as an IV infusion, usually every few weeks, under medical supervision. Skipping doses or delaying treatment may reduce its benefits. Attend all appointments and inform your doctor of any side effects or new symptoms. Regular monitoring may be needed to track your response and adjust the treatment if required.

Common side effects of Tevimbra 100mg Injection can be fatigue, muscle or joint pain, cough, and weight loss. Some patients may experience changes in blood test results, including low hemoglobin, decreased lymphocyte or sodium levels, elevated blood sugar, or elevated liver enzymes. Some have even seen anemia and low albumin levels. These side effects are generally controllable, but frequent follow-up visits and blood tests are necessary to monitor your body's response to the medication.

Tevimbra 100mg Injection must not be taken by a person who has experienced a severe reaction to this drug or one of its ingredients. People with active autoimmune diseases, liver conditions, or past organ transplants must tell their doctor before treatment. Frequent blood tests must be done to check liver function, counts of blood cells, and electrolytes. It should be avoided by pregnant women or those planning to become pregnant, as it can harm the unborn child. Always talk to your doctor regarding your entire medical history before

Imfinzi 120 mg Infusion is an anti-cancer medicine used in the treatment of unresectable, stage III non-small cell lung cancer (NSCLC). Imfinzi 120 mg Infusion is also used in combination with tremelimumab-actl and platinum-based chemotherapy for treatment of metastatic NSCLC, in combination with etoposide and either carboplatin or cisplatin for treating extensive-stage small cell lung cancer, in combination with gemcitabine and cisplatin in treating metastatic biliary tract cancer, and in combination with tremelimumab-act in treatment of unresectable hepatocellular cancer.

Imfinzi 120 mg Infusion contains Durvalumab, which belongs to the class of monoclonal antibodies. It works by inhibiting the action of a programmed death ligand receptor-1 (PD-L1), thereby stopping the abnormal growth of cancer cells.

Imfinzi 120 mg Infusion may cause certain side effects such as diarrhoea, nausea, vomiting, tiredness, itching, rash, headache, fever, shortness of breath, muscle/joint pain, abdominal pain, loss of appetite and injection site reactions. Inform your doctor if any of these side effects persist for longer. Imfinzi 120 mg Infusion will be administered by an oncologist trained in administering anti-cancer agents.

Avoid receiving Imfinzi 120 mg Infusion and inform your doctor if you are allergic to it or any other components of it. This medicine is known to cause embryo-fetal toxicity. Hence, it is not recommended for use in pregnancy. Before taking Imfinzi 120 mg Infusion , tell your doctor if you have/had liver or kidney disease, autoimmune disorders such as ulcerative colitis or Crohn's disease, a history of organ transplants, received an allogeneic stem cell transplant, or had radiation treatment to the chest, and myasthenia gravis. Avoid breastfeeding while taking this Imfinzi 120 mg Infusion .

Kadcyla 100mg Injection is a medicine used to treat a certain type of cancer called HER2-positive metastatic breast cancer. It specifically targets the HER2 protein in cancer cells. This slows tumor growth and reduces tumor size with minimum effects on healthy cells.

Kadcyla 100mg Injection is administered through an intravenous (IV) infusion under the supervision of a doctor or a nurse, typically in a clinic or hospital setting. It is given once every three weeks, and each infusion session may take around 3090 minutes, depending on individual treatment needs. Attend all scheduled infusion sessions to maintain consistent drug levels for maximum benefits.

Common side effects of Kadcyla 100mg Injection include fatigue, nausea, vomiting, headache, constipation, mild liver enzyme changes, and muscle or joint pain. If you experience nausea, try eating small, frequent meals and avoid heavy or greasy foods. Fatigue can be managed by resting when needed and pacing activities. Let your doctor know if any of these side effects persist or worsen. They may be able to help ways to reduce or prevent the side effects.

Before receiving this medicine, inform your doctor if you have a history of liver or heart issues, as this medication can affect these organs. This treatment is not recommended for pregnant women, as it may harm the unborn baby; women of childbearing age should use effective contraception during treatment and for several months after. Additionally, avoid breastfeeding during and after treatment, as the drug may pass into breast milk.